https://www.selleckchem.com/pr....oducts/pf-07265807.h
Treatment for one patient with upper urinary tract cancer on pembrolizumab was postponed for three weeks due to adverse events of the vaccine. Only 0.6% of the adverse events of the vaccine required postponement of treatment, suggesting that vaccination is safe even during cancer drug therapy. Only 0.6% of the adverse events of the vaccine required postponement of treatment, suggesting that vaccination is safe even during cancer drug therapy. The standard of treatment for esophageal cancer with adjacent organ invasion (T4) has not b
Curtir
Comentario
Compartilhar
